Analysed Viridian Therapeutics Inc (VRDN:NASDAQ) News Sources
RBC Capital Lowers Its Price Target on Viridian Therapeutics, Inc. (VRDN) to $42 and Maintains an Outperform Rating
Yahoo Finance
Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Xencor (XNCR)
The Globe and Mail
What is the current price of Viridian Therapeutics Inc (VRDN:NASDAQ)?
The current price of Viridian Therapeutics Inc (VRDN:NASDAQ) is $28.34.
Viridian Therapeutics Inc (VRDN:NASDAQ) absolute price change since previous trading day?
The absolute price change of Viridian Therapeutics Inc (VRDN:NASDAQ) since the previous trading day is $-0.55.
Viridian Therapeutics Inc (VRDN:NASDAQ) percentage price change since previous trading day?
The percentage price change of Viridian Therapeutics Inc (VRDN:NASDAQ) since the previous trading day is -1.90%.
What is This Week's average sentiment score for Viridian Therapeutics Inc (VRDN:NASDAQ)?
This Week's average sentiment score for Viridian Therapeutics Inc (VRDN:NASDAQ) is 88 out of 100.
What is This Week's average sentiment for Viridian Therapeutics Inc (VRDN:NASDAQ)?
This Week's sentiment for Viridian Therapeutics Inc (VRDN:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.